BMS Plans Appeal After Sandoz And Teva Eliminate UK Eliquis Patent
UK Ruling Saw Local Counterpart Of European Apixaban Patent Declared Invalid
Apixaban has this month been the subject of a decision, an appeal and further litigation • Source: Alexey Panferov / Alamy Stock Photo 
